Edition:
India

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

5.19USD
2:29am IST
Change (% chg)

$-0.05 (-0.95%)
Prev Close
$5.24
Open
$5.25
Day's High
$5.28
Day's Low
$5.13
Volume
67,425
Avg. Vol
25,274
52-wk High
$13.18
52-wk Low
$5.13

Chart for

About

Obalon Therapeutics, Inc. is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide... (more)

Overall

Beta: --
Market Cap(Mil.): $169.25
Shares Outstanding(Mil.): 16.82
Dividend: --
Yield (%): --

Financials

BRIEF-Obalon Therapeutics prices offering of 5.5 mln shares at $5.50 per share

* OBALON THERAPEUTICS INC - ‍PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 5.5 MILLION SHARES OF COMMON STOCK AT A OFFERING PRICE OF $5.50 PER SHARE​ Source text for Eikon: Further company coverage:

19 Jan 2018

BRIEF-Obalon Therapeutics Announces Proposed Public Offering Of $35 Mln Shares

* OBALON THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

17 Jan 2018

BRIEF-Obalon Therapeutics Q3 loss per share $0.55

* Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

03 Nov 2017

BRIEF-Obalon Therapeutics & Sono Bello announce agreement to offer novel weight loss treatment

* Obalon Therapeutics Inc and Sono Bello announce agreement to offer novel weight loss treatment in Sono Bello centers

03 Nov 2017

BRIEF-Obalon Therapeutics files for mixed shelf of up to $100 mln

* Says in addition, selling stockholder may offer and sell up to 150,000 shares of co's common stock Source text: http://bit.ly/2z5bZGj Further company coverage:

02 Nov 2017

BRIEF-Obalon Q2 loss per share $0.46

* Q2 earnings per share view $-0.44 -- Thomson Reuters I/B/E/S

02 Aug 2017

Earnings vs. Estimates